Dear President Trump: Don’t destroy the FDA we know and respect
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
On Tuesday, a group of Big Pharma execs from Merck, J&J, Amgen, Eli Lilly and Celgene gathered to pay court to President Donald Trump at the White House. Trump didn’t disappoint either his admirers or his critics, launching into a full throated harangue on high drug prices while vowing to the collection of CEOs that he was about to erase a large number of the regulations on drug development to speed the arrival of a new generation of drugs at a lower cost.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.